Le Lézard
Classified in: Health, Business
Subjects: LIC, VEN

Empower Aesthetics Highlights Recent Strategic Partnerships: Uplifting Businesses of Medical Aesthetic Industry Entrepreneurs


Private Equity-Backed Platform Pursues New Clinical Partnerships and Sparks Growth of Medical Aesthetics Industry Across the U.S.

CHICAGO , March 14, 2024 /PRNewswire/ -- Empower Aesthetics ("Empower" or "the Company"), a national medical aesthetics platform, continues its fast-paced growth while at the same time seeking new clinical partnerships to build out the platform.

Empower Aesthetics was formed in July 2023 by Shore Capital Partners ("Shore" or "Shore Capital"), a Chicago-based private equity firm focused on microcap investing. Under the leadership of Chief Executive Officer, Alyssa Rapp and Empower's Board of Directors, the Company has solidified four recent partnerships with leading medical aesthetics practices in key U.S. markets:

"We are committed to building a constellation of clinical partners that are amongst the brightest stars in the space, who deliver and uphold the highest standards of clinical excellence," said Rapp. "The prospect of establishing additional clinical partnerships in the immediate future is a source of great enthusiasm for both me, our executive leadership team and Empower's Board of Directors."

Empower Aesthetics is actively pursuing an acquisition strategy, looking for like-minded, growth-oriented entrepreneurs in aesthetics to join a trusted network of clinical leaders, share best practices and deliver superior clinical outcomes.

By implementing strategic and operational initiatives intended to elevate the Company's partners, Empower Aesthetics helps clinical leaders grow their businesses, achieve their financial goals, streamline operations and connect with new clients. This private equity-backed support supplies Empower's partners with the resources needed to help grow their businesses, invest in employees, fine-tune operations and see more patients.

To learn more about Empower Aesthetics, please visit www.empower.spa, or email [email protected].

About Empower Aesthetics
Empower Aesthetics is a national aesthetics platform that provides the tools, support and strategy to empower aesthetic owners and practices to reach new heights while maintaining the highest quality of care. With corporate presence in Chicago, Illinois and Austin, Texas, Empower is looking for providers with whom to partner and grow.  To learn more about Empower Aesthetics, please visit www.empower.spa, or email [email protected].

About Shore Capital Partners
Shore Capital, a Chicago-based private equity firm with an office in Nashville, is an investor in microcap companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore's strategy is to support management partners to grow faster with less risk, through access to capital; world-class board and operational resources; and unmatched networking, development, and shared learnings across the portfolio. From 2020-2023 Shore received recognition from Inc. Magazine as a 4x Top Founder-Friendly Investor and by Pitchbook for being the global leader in private equity total deal volume. Shore targets investments in proven, successful companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has approximately $6 billion of assets under management through various investment vehicles. For more information, please visit www.shorecp.com.

Media Contact: Alec Miszuk | Fishman PR | [email protected] | (630) 484-0797

SOURCE Empower Aesthetics


These press releases may also interest you

at 06:17
Nationally recognized women's health advocate and former White House aide Alejandra Campoverdi will be Northeastern Illinois University's May 2024 Commencement speaker. Campoverdi is the bestselling author of "First Gen: A Memoir", which examines the...

at 06:10
Arcturis Data Limited ("Arcturis"), a UK leader in Real World Data and Evidence, and Oxford University Hospitals NHS Foundation Trust ("OUH") a global exemplar in clinical, research and digital health excellence, announce today that they are to...

at 05:45
The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. . Shareholders who purchased shares of BLUE...

at 05:44
According to the latest BCC Research study, the demand for Pharmacy Automation: Technologies and Global Markets is growing from $7.8 billion in 2023 to $12.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023...

at 05:05
Sun Nuclear, a Mirion Medical company, will feature new and enhanced solutions for better Quality Management at the ESTRO Annual Meeting, May 3-6, in Glasgow, Scotland. The Sun Nuclear booth (#930) will highlight demonstrations and insights on the...

at 04:32
According to the latest BCC...



News published on and distributed by: